Related references
Note: Only part of the references are listed.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
Sara Monti et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
Durga Prasanna Misra et al.
CLINICAL RHEUMATOLOGY (2020)
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
Angela Ceribelli et al.
JOURNAL OF AUTOIMMUNITY (2020)
Baricitinib for COVID-19: a suitable treatment?
Ennio G. Favalli et al.
LANCET INFECTIOUS DISEASES (2020)
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic
Lorenzo D'Antiga
LIVER TRANSPLANTATION (2020)
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Yan Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients
Amr H. Sawalha et al.
CLINICAL IMMUNOLOGY (2020)
Share Paper
